Vimarsana
Biggest News Aggregation in the World

Page 13 - Caredx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caredx Today - Breaking & Trending Today

Shane Nigam's letter sent to producer Sophia Paul which led to his Kerala film ban is OUT; Actor REACTS - Vimarsana News

Shane Nigam's letter sent to producer Sophia Paul which led to his Kerala film ban is OUT; Actor REACTS

Here’s a letter from Shane Nigam that clarifies the reasons for his ban from films.

CareDx, Inc (NASDAQ:CDNA) Receives Average Rating of "Hold" from Analysts - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Receives Average Rating of "Hold" from Analysts

CareDx, Inc (NASDAQ:CDNA – Get Rating) has been given an average rating of “Hold” by the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price […]

Source: wkrb13.com
CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference - Vimarsana News

CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

Posters and Symposium Highlight Utility of AlloSeq for HLA Typing, Organ Transplant Monitoring and Hematopoietic Stem Cell Monitoring ... | April 25, 2023

CareDx, Inc.: CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference - Vimarsana News

CareDx, Inc.: CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

Posters and Symposium Highlight Utility of AlloSeq for HLA Typing, Organ Transplant Monitoring and Hematopoietic Stem Cell Monitoring CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company

CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation - Vimarsana News

CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation

Data Highlights the Value of HeartCare and AlloSure Lung in Clinical Practice Leading Experts Present Latest Advancements in Heart and Lung Transplantation During CareDx Symposia ... | April 19, 2023